Testosterone patch drives women crazy in bedroom, but cancer risk uncertain
By Will Dunham WASHINGTON (Reuters) - Beta carotene, vitamin C and vitamin E supplements taken for years failed to lower overall cancer risk in the latest study to cast doubt on the possibility that such dietary supplements can prevent cancer. The findings, published on Tuesday in the Journal of the National Cancer Institute, followed two other important
Full Post: Antioxidants fail again in cancer prevention study
Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain.
Off-label use of testosterone is allowed in the United States although the FDA has not approved this treatment for low sexual function or hypoactive sexual desire disorder particularly in postmenopausal women who experience surgery induced menopause.
The review titled “breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy” was conducted by Bitzer JJ and colleagues of University-Women’s Hospital Basel in Basel, Switzerland and published in March 2008 in the journal Maturitas.
The authors searched records in Medline from 1969 through July 2007 and MEBASE and Biosis from 1990 through July 2007 for original reports in English and French. They found no prospective randomized clinical trials were ever conducted to evaluate the risk of breast cancer from the testosterone treatment.
They found only five studies (two case-control studies, two cohort studies and one retrospective observational study), but the results were inconsistent. The researchers said all studies had severe methodological limitations and formulations and dosages used were not optimal.
They conclude that “at present, there are no valid randomized or observational clinical studies that provide evidence that the addition of testosterone to conventional postmenopausal hormone therapy influences breast cancer risk.”
One recent trial conducted by Susan Davis of Monash University in Melbourne, Australia and colleagues showed that use of testosterone patches made by Procter & Gamble for 24 weeks more than doubled monthly sexual episodes at a high dose in women with low sexual desire and activities.
But in the one year trial, published in the November 2008 issue of the New England Journal, breast cancer was diagnosed in four of the 534 postmenopausal women treated with the male hormone compared to none in the 277 placebo recipients.
--------------------------------------------------------------------------------------------Related Posts:
The trial of Procter & Gamble’s Intrinsa testosterone patches for women was sponsored by Procter & Gamble and the treatment was indicated for hypoactive sexual desire disorder (HSDD). “HSDD is characterized as a lack or absence of sexual fantasies and desire for sexual activity for some period of time”, Wikipedia states. An estimated 26.7%
Full Post: Male hormone drives women crazy in bedroom - study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer. Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters
Full Post: High insulin levels may increase breast cancer risk
--------------------------------------------------------------------------------------------
Thursday October 16, 2008 (foodconsumer.org) — In the National Breast Cancer Awareness Month, you may do something to help yourselves reduce the risk of breast cancer. But first, equip yourselves with current knowledge about how to prevent the disease. We have published quite a few articles on breast cancer prevention because it is better
Full Post: Radiotherapy raises risk of contralateral breast cancer - Study
--------------------------------------------------------------------------------------------
Do you know that breast cancer is the most common cancer among women? Breast cancer is also the second leading cause of cancer related deaths in American women. Most cases of breast cancer are diagnosed when a mammogram reveals a lump. A change in the texture of breast tissue can also be a warning sign
Full Post: Nolvadex PCT
--------------------------------------------------------------------------------------------
WASHINGTON - Women who take hormone replacement therapy to treat menopause symptoms do not have a higher than usual risk of heart attack, especially if they use a cream or skin patch or take cyclic hormone combinations, Danish researchers reported yesterday. Their study, published in the European Heart Journal, suggests it is not hormone replacement therapy
Full Post: Study finds HRT does not increase heart attack risk